RGEN
Repligen Corporation
NASDAQ: RGEN · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$113.11
-3.68% today
Updated 2026-04-29
Market cap
$6.38B
P/E ratio
131.52
P/S ratio
8.64x
EPS (TTM)
$0.86
Dividend yield
—
52W range
$110 – $176
Volume
0.9M
Repligen Corporation (RGEN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$113.11
12-Month target
$40.25
2030 Target
—
Intrinsic (DCF)
$160.09
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.7B | $0.8B | $0.6B | $0.6B | $0.7B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 6.62%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.